To reduce waiting time in PMB clinics, and patient journey on Single cancer pathway.
Design
Differential triage based on risk stratification in USC PMB clinics. Patients with true PMB and with unscheduled bleeding on HRT with risk factors triaged to 2WW. Those with unscheduled bleeding on HRT without risk factors to 6WW clinic. Introduced from March 2024 onwards. Data analysed over 4 months.
Setting
One stop PMB clinics, Large DGH in Newport, Wales Population: Aneurin Bevan Health board Hospitals with a population of 600,000.
Main outcome measures
Time to first outpatient appointment.
Results
Nine hundred and two referrals. 48.22% were not on HRT. 49.88 % were on HRT. 20.44% were on HRT with risk factors. The first outpatient appointment improved from 17.6% in April to 64.6% (p < .0001) in September. Patients breaching the Single Cancer Pathway went down from 11 in April to 2 in September. 88% patients discharged after the FOA. One hundred and ninety-two (21.28%) had a hysteroscopy polypectomy. Forty-four cancers in the true PMB group and 1 cancer in the HRT group. There was no difference in the average BMI between the cancer and benign patients. Patients with endometrial cancer were significantly older (p < .0001***).
Conclusion
Differential triage has reduced the waiting times in PMB clinics.
World Cancer Research Fund/American Institute for Cancer Research. Continuous update project expert report 2018. Diet, nutrition, physical activity and endometrial cancer. 2018.
3.
MossELMorganGMartinAP, et al.Surgical trends, outcomes and disparities in minimal invasive surgery for patients with endometrial cancer in England: a retrospective cohort study. BMJ Open2020; 10(9): e036222.
4.
NjokuKBarrCEHotchkiesL. et al. Impact of socio-economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis. BJOG. 2021 Jun; 128(7): 1215–1224.
5.
GredmarkTKvintSHavelG, et al.Histopathological findings in women with postmenopausal bleeding. Br J Obstet Gynaecol1995; 102(2): 133–136.
6.
ClarkeMALongBJDel Mar MorilloA, et al.Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Intern Med2018; 178(9): 1210–1222.
7.
AlsugeirDWeiLAdesuyanM. et al. Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study. BJGP Open. 2022; 6(4): BJGPO.2022.0126.
8.
Management of unscheduled bleeding on hormone replacement therapy (HRT)on behalf of the British Menopause Society, in partnership with the British Society of Gynaecological Endoscopy, British Gynaecological Cancer Society, Faculty of Sexual & Reproductive Healthcare, Getting It Right First Time (GIRFT), Royal College of General Practitioners and the Royal College of Obstetricians & Gynaecologists.
9.
Demography and migration in Wales, Census 2021. Unrounded population and household estimates, including overview of the non-UK born population and characteristics of households and residents in Wales from 2021 Census.Wales.Gov.Uk.
10.
SIGN. Scottish intercollegiate guidelines network: investigation of postmenopausal bleeding: a national clinical guideline, 2002 21st November 2023. Available from: Investigation of post-menopausal bleeding (sign.ac.uk).
11.
LongBClarkeMAMorilloADM, et al.Ultrasound detection of endometrial cancer in women with postmenopausal bleeding: systematic review and metaanalysis. Gynecol Oncol2020; 157(3): 624–633.
12.
BurbosNMusondaPDuncanTJ, et al.Postmenopausal vaginal bleeding in women using hormone replacement therapy. Menopause Int2012; 18(1): 5–9.
13.
EttingerBLiDKKleinR. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Fertil Steril1998; 69(5): 865–869.
14.
al-AzzawiFHabibaM. Regular bleeding on hormone replacement therapy: a myth?Br J Obstet Gynaecol1994; 101(8): 661–662.
15.
StutePMarsdenJSalihN, et al.Reappraising 21 years of the WHI study: putting the findings in context for clinical practice. Maturitas2023; 174: 8–13.
16.
StuteP,NeulenJWildtL. The impact of micronized progesterone on the endometrium: a systematic review. Climacteric2016; 19:316–328.
17.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trialJAMA2002; 288:321–333.
18.
BhaskaranKDouglasIForbesH, et al.Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet2014; 384: 755–765.
19.
MackintoshMLCrosbieEJ. Obesity-driven endometrial cancer: is weight loss the answer?BJOG2013; 120(7): 791–794.
20.
CrosbieEJZwahlenMKitchenerHC, et al.Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev2010; 19(12): 3119–3130.
21.
RenehanAGSoerjomataramITysonM, et al.Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer2010; 126(3): 692–702.
22.
FerrazziETorriVTrioD, et al.Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study. Ultrasound Obstet Gynecol1996; 7(5): 315–321.
23.
GullBKarlssonBMilsomI, et al.Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol2003; 188(2): 401–408.
24.
GuptaJKChienPFVoitD, et al.Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand2002; 81(9): 799–816.
25.
TimmermansAOpmeerBCKhanKS, et al.Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol2010; 116(1): 160–167.
26.
TimmermansAOpmeerBCVeersemaS, et al.Patients’ preferences in the evaluation of postmenopausal bleeding. Bjog2007; 114(9): 1146–1149.62.
27.
FungLWYCheungECWWongASW, et al.Patient acceptance of transvaginal sonographic endometrial thickness assessment compared with hysteroscopy and biopsy for exclusion of endometrial cancer in cases of postmenopausal bleeding. Hong Kong Med J2022; 28(2): 133–139.
28.
GullBKarlssonBMilsomI, et al.Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol2003; 188(2): 401–408.
29.
EvansIReiselDJonesA. et al. Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study int he UK. Lancet Oncol. 2023; 24(12): 1375–1386.
